EVEGYN vaginal ovule (600 mg/1000 mg/100 mg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EVEGYN vaginal ovule (600 mg/1000 mg/100 mg), covering 2025-02-07 to 2025-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule [Phase 1]